A single study suggests that the gel results in an average of 2% weight loss, less than the minimum criterion
For non-obese individuals diagnosed with Type 2 diabetes, Semaglutide GLP-1 can still be prescribed, but it is primarily for blood sugar control rather than weight loss
Personalized Carb Intake With PlexusDx Precision Testing Individual responses to carbohydrates vary based on genetics, particularly in genes controlling appetite, energy expenditure, and glucose metabolism
The shift from simple diabetic syringes to intelligent, automated systems reflects a broader commitment to holistic patient care
Maintain a Healthy Diet Maintaining a healthy diet is paramount after discontinuing semaglutide
In REDEFINE 1 (no diabetes), CagriSema produced an estimated mean weight change of about 20.4% at 68 weeks